Point72 Asia (Singapore)’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-996
Closed -$5.96K 897
2024
Q4
$5.96K Buy
996
+47
+5% +$281 ﹤0.01% 775
2024
Q3
$9.26K Sell
949
-944
-50% -$9.21K ﹤0.01% 869
2024
Q2
$38.8K Buy
+1,893
New +$38.8K 0.01% 721